throbber
j
`
`··· ',
`
`53?06
`1 5f; 0 R
`SC!0014247 2 0.90192
`UhTUEFSJn·· OF. !·JI.SCOUSJN
`S TEE:NE:OCK f'IEi'IOP I AL. LlBRAR)-'
`5.50 E:RE:COCI<.' [it?
`NFIDIEDN IH 5.3?06
`
`Ill
`Vol 53
`September 1992
`No. 9
`~~~~~~~~=:[)
`
`CEV Exhibit 1006_001
`
`

`

`Antibody response to and maternal immunity
`from an experimental psittacine beak and feather
`disease vaccine
`
`Branson W. Ritchie, DVM, PhD; Frank D. Niagro, PhD; Kenneth S. Latimer, DVM, PhD; W. L. Steffens, PhD;
`Denise Pesti, MS; Raymond P. Campagnoli, MS; Phil D. Lukert, DVM, PhD
`
`SUMMARY
`Adult umbrella cockatoos, Moluccan cockatoos, Mrican
`grey parrots, and a yellow-headed Amazon parrot ~ere
`inoculated IM or sc with 13-propiolactone-treated psitta(cid:173)
`cine beak and feather disease (PBFD) virus. Thirty- to 45-
`day-old African grey parrot, umbrella cockat?o, and s~l­
`phur-crested cockatoo chicks also ;-ver~ va.ccn~.a~~d with
`the same inoculum. The hemagglutmahon mhibitwn (HI)
`and agar-gel diffusion tests wer~ used to. assay f?r P?St(cid:173)
`vaccination development of anh-PBFD virus antibodies.
`All adult vaccinates seroconverted and had increases in
`HI and precipitating antibodies. The vaccinated chicks had
`increased concentrations of HI antibodies, but precipitat(cid:173)
`ing antibodies could not be detected. To demonstrate th~t
`chicks from vaccinated hens are protected from PBFD vi(cid:173)
`rus challenge, 3 African grey parrot chicks and 2 ~m­
`brella cockatoo chicks from vaccinated hens and 1 Afncan
`grey parrot chick and 1 umbrella cock~~oo chick ~rom
`nonvaccinated hens were exposed to punfied PBFD virus.
`Chicks from the vaccinated h ens remained clinically nor(cid:173)
`mal during the 50-day t est period. Chicks from the non(cid:173)
`vaccinated hens developed clinical and histologic lesions
`of PBFD. Infected tissues from these birds were confirmed
`to contain viral antigen, using immunohistochemical
`staining techniques. The PBFD virus was recovered from
`the affected birds. These findings indicate that adult and
`30- to 45-day-old psittacine birds will seroconvert follow(cid:173)
`ing vaccination with 13-propiolactone-tr eated PBFD virus.
`Also h ens inoculated with 13-propiolactone-treated PBFD
`viru~ produce chicks that are, at least temporarily, resis(cid:173)
`tant to virus challenge.
`
`Psittacine beak and feather disease (PBFD) is caused by
`a 14- to 17-nm nonenveloped virus containing single-
`
`Received for publication Oct 17, 1991.
`From the Departments of Small Animal Medicine (Ritchie), Medical Microbi(cid:173)
`ology (Niagro, Lukert, Pesti), Pathology (Latimer, Campagnoli), Anatomy and
`Radiology (Steffens), College of Veterinary Medicine, University of Georgm, Ath-
`ens, GA 30602.
`.
`Supported in part by funds from the International Avian Research F?undatwn,
`Terry Clyne, Richard and Luanne Porter, Charles G?ddard Founda~IO?, . Isabel
`Taylor, Avicultural Society of Greater Cincinnati, B1rd Club~ of V1rg~ma, the
`Association of Avian Veterinarians, Miami Parrot Club, and Ze1gler Brothers Inc.
`The authors thank Mary B .. Ard, Glenn Weatherly, J anice Matthews, a nd the
`staff of the Educational Resource Center for technical assista nce.
`
`0
`
`0
`
`stranded circular DNA. 1· 3 The PBFD virus shares ultra(cid:173)
`structural and nucleic acid similarities with 2 other re(cid:173)
`cently described viruses, the apparently apathogenic
`0 k
`4 7 p 't
`porcine circovirus and the chic en anemia v1rus. ·
`s1 -
`tacine beak and feather disease is characterized by the
`progessive formation of dystrophic feathers. Beak lesions
`may or may not develop. This disease has been reported
`in many species of captive and free-ranging Old World
`psittacine birds.8 -
`12 Viral infections have also been doc(cid:173)
`umented in New World psittaciformes, including Amazon
`parrots and a Scarlet macaw. 2•13 •14 Neither the e?'act_ host
`range of the PBFD virus nor seroprevaleJ?-ce of ;;mti~odies to
`the virus in either captive or free-ranging psittacme pop(cid:173)
`ulations is known.
`The first sign of PBFD is the appearance of necrotic,
`abnormally formed feathers. The type of feathers that are
`initially involved depends on the stage of molt when the
`clinical signs of disease are first manifested. In young
`birds, all of the feather tracts may be affected during a
`1-week period, whereas in older birds, the disease ~s more
`prolonged, with progressive feather changes durmg en(cid:173)
`suing molts. 3•8· 10•15 •16 If beak lesions develop, they may
`include palatine necrosis, progressive elongation, and
`transverse or longitudinal fractures. 3 •8 •
`11
`15
`•
`Subjectively, PBFD can be diagnosed by the ident~fi~a­
`tion of basophilic intranuclear and intracytoplasmic m(cid:173)
`clusion bodies within infected feather epithelial cells or
`m acrophages, respectively. 2 •8 · 11•13 -1 8 Because other vi(cid:173)
`ruses may induce similar-appearing inclusio_n bodies! a
`confirmatory diagnosis requires the use of viral-spec.lfic
`antibodies or nucleic acid probes to demonstrate PBFD vrral
`antigen or viral DNA, respectivelyY-19 Viral-specific D~A
`probes also can be used to detect PBFD viral nucleic actd
`in WBC of infected birds.19
`The hemagglutination inhibition (HI) test has been u~ed
`to detect anti-PBFD virus antibody titers in birds Wlth
`active viral infections and in clinically normal birds nat(cid:173)
`urally exposed to the virus. Birds with activ~ PBFD v~rus
`infections have been found to have lower anb-PBFD v1rus
`antibody titers than birds that had been ~xpose? to the
`virus, but remained clinically normal. Th1s findmg sug·
`gests that some birds exposed to the virus are able tf
`mount an effective immune r esponse. 20 The purpose ~
`the study reported h ere was to determine whether antJ·
`PBFD virus antibodies could be induced by experimental
`inoculation with 13-propiolactone-treated virus and whether
`
`1512
`
`Am J Vet Res, Vol 53, No. 9, September 1992
`
`CEV Exhibit 1006_002
`
`

`

`vaccinated hens produced chicks that were resistant to
`pBFD virus challenge.
`
`Materials and Methods
`Birds-A group of clinically normal 30- to 45-day-old
`African grey parrots (Psittacus erithacus erithacus), um(cid:173)
`brella cockatoos (Cacatua alba), and sulphur-crested
`cockatoos (C sulphurea), and pairs of adult male and fe(cid:173)
`male umbrella cockatoos, Moluccan cockatoos (C moluc(cid:173)
`censis), African grey parrots, and a yellow-headed Amazon
`parrot (Amazona ochrocephala 01·atrix) were used in this
`study. The adult pairs were housed in drop-through flight
`cages and were fed a mixture of seeds, fresh vegetables,
`and commercial pellets. The chicks were housed in wire(cid:173)
`bottom baskets that were placed in temperature-con(cid:173)
`trolled incubators. Breeding pairs of umbrella cockatoos
`and African grey parrots were inoculated with 13-propio(cid:173)
`lactone-treated, Freund's adjuvanted PBFD virus. Control
`breeding pairs of umbrella cockatoos and African grey
`parrots were not vaccinated. Eggs produced by the cock(cid:173)
`atoos were removed from the nest boxes 5 to 10 days after
`the last egg was laid and placed in an incubator.a One
`clutch of African grey parrots were allowed to incubate
`their eggs and neonates were removed from the nest box
`when they were 2 to 5 days old. Eggs from another pair
`of African grey parrots were removed from the nest sev(cid:173)
`eral days before hatching and were placed in an incuba(cid:173)
`tor.a
`
`Preparation of antigen-Feather follicle tracts from a
`diseased Moluccan cockatoo (vaccine isolate) and anum(cid:173)
`brella cockatoo (challenge isolate) were excised and placed
`in phosphate-buffered saline solution (PBSS, 0.05M phos(cid:173)
`phate buffer, 0.15M NaCl, pH 7.2). Virus was extracted
`by use of a tissue homogenizer.b The suspensions were
`clarified by centrifugation (30,000 x g for 20 minutes, 4
`C) followed by 46,000 x g for 20 minutes, 4 c.c The clar(cid:173)
`ified supernatant fluid was layered over 45% (w/v) su(cid:173)
`crose in PBSS and centrifuged (140,000 x g for 2 hours,
`4 C)c to obtain crude viral pellets. Pellets were resus(cid:173)
`pended in PBSS, adjusted to 1.37 g/ml with cesium chlo(cid:173)
`ride, and centrifuged to equilibrium (270,000 x g for 16
`hours, 20 C).c The gradient was collected with a density
`gradient fractionator.d Fractions containing virus were
`dialyzed against PBSS and were further purified by cen(cid:173)
`trifugation through linear sucrose gradients (20 to 60%
`w/v) in PBSS buffer (270,000 x g for 90 minutes, 4 C).c
`Gradients were collected as described. Fractions contain(cid:173)
`ing purified virus were dialyzed against PBSS and stored
`at -20 C.
`
`:Vaccination-Twenty microliters (10,240 hemagglutin(cid:173)
`ating [HA] units) of virus purified from an infected Mol(cid:173)
`uccan cockatoo was mixed with 13-propiolactone according
`to published procedures. 21 After a 2-hour incubation at
`37 C, 20 J.Ll of virus was mixed with 70 J..Ll ofPBSS and 100
`~l of Freund's complete adjuvant (for the first inocula(cid:173)
`~Ion) or Freund's incomplete adjuvant (for all subsequent
`Inoculations). Test birds were placed under isoflurane
`
`-: ~!Umbach incubator, Swan Creek Supply, Saginaw, Mich.
`
`lssue homogenizer, Tekmar Co, Cincinnati, Ohio.
`,
`, gltr~centrifuge, Beckman Instruments, Palo Alto, Calif.
`ens1ty grad ient fractionator, Isco, Lincoln, Neb.
`
`anesthesia and were vaccinated either IM (1 bird) or sc
`(all other birds) with the 13-propiolactone-treated, adju(cid:173)
`vanted virus preparation. A male Moluccan cockatoo was
`inoculated with adjuvant and 13-propiolactone in PBSS as
`a reagent control. The birds were vaccinated on days 0,
`7, and 14. Blood samples were collected by jugular veni(cid:173)
`puncture on days 0, 7, 14, and 21. The blood samples were
`placed in glass tubes and allowed to clot. The clot was
`separated from the serum by centrifugation, and the serum
`was removed from the tube and stored frozen at - 20 C.
`
`Hemagglutination and HI tests-Blood from a goffin
`cockatoo (C goffini) was collected in Alsever's solution,
`using care to prevent clotting. Cells were stored at 4 C
`for not more than 1 week. Erythrocytes were washed 3
`times in PBSS (pH 7.2) and resuspended in the same buffer
`to produce a 25% stock solution. A 0. 75% working dilu(cid:173)
`tion of erythrocytes was made in PBSS immediately before
`use. Stock solutions were used for up to 7 days, but were
`discarded if hemolysis was evident. Tests were performed
`in 96-well plastic round-bottom microtitration plates.
`The HA test was performed by making serial twofold
`dilutions (starting dilution of 1:50) of purified concen(cid:173)
`trated PBFD virus in PBSS. Cockatoo erythrocytes (50 J..Ll,
`0. 75% suspensions) were added to each well. The tests
`were read when a clear button had formed in the bottom
`of all wells, usually within 30 to 45 minutes.
`Serum from each bird to be tested by HI was heated at
`56 C for 30 minutes. The serum samples were diluted 1:40
`in PBSS, adsorbed with 0.2 volumes of a 25% (v/v) suspen(cid:173)
`sion of the cockatoo erythrocytes, and incubated for at
`least 2 hours at room temperature (25 C) or overnight at
`4 C. Erythrocytes were removed by low-speed centrifu(cid:173)
`gation. Serial dilutions (twofold, 1:40 initial dilution) were
`made in a round-bottom plastic microtitration plate. An
`equal volume (50 J..Ll, 64 HA units as determined by the
`HA test) of PBFD virus was added to each serum dilution.
`After a 1-hour incubation period at 25 C, 100 J..Ll of 0. 75%
`cockatoo erythrocytes was added to each well. The tests
`were read after the control cells formed a clear button,
`and end points were determined as the last serum dilu(cid:173)
`tion that prevented HA.
`
`Agar gel diffusion test-Serum samples obtained from
`the test birds at day 0 and 21 following vaccination were
`tested for precipitating antibodies. Noble agar (0. 7%) was
`prepared in PBSS, pH 7.4. In the agar, 6 wells were made
`around a central well. Serum from each bird, undiluted
`and at dilutions of 1:5, 1:10, 1:20, 1:40, and 1:80, was
`placed in the 6 wells. Thirty microliters of purified PBFD
`virus was placed in the central well and the plates were
`incubated overnight at 25 C. With a high-intensity light,
`the plates were examined for formation of precipitin lines.
`Normal rabbit serum was used as a negative control, and
`rabbit serum containing anti-PBFD virus antibodies was
`used as a positive control.
`
`Psittacine beak and feather disease virus challenge(cid:173)
`Three African grey parrot chicks and 2 umbrella cockatoo
`chicks from vaccinated hens and 1 African grey parrot
`chick and 1 umbrella cockatoo chick from a nonvaccina(cid:173)
`ted hen were exposed to purified PBFD virus. The birds
`were given a total of 30 J..Ll of purified virus (1,500,000 HA
`units) at ages 3 to 5 days and 6 to 8 days. For exposure,
`
`Arn J Vet Res, Vol 53, No. 9, September 1992
`
`1513
`
`CEV Exhibit 1006_003
`
`

`

`30 f.Ll of purified virus was mixed in 250 f,Ll of PBSS. One
`hundred microliters of this solution was given orally, an(cid:173)
`other 100 f,Ll sc, and 50 f,Ll intracloacally. All birds were
`examined daily for clinical signs of disease.
`
`Histologic examination and immunohistochemical
`analysis-The African grey parrot chick and umbrella
`cockatoo chick from nonvaccinated hens died and were
`necropsied when they were 44 and 4 7 days old, respec(cid:173)
`tively. A complete set of tissues including liver, spleen,
`kidney, heart, intestines, pancreas, proventriculus, ven(cid:173)
`triculus, thymus, bone marrow, cloaca, and brain were
`fixed in neutral buffered 10% formalin solution. Sections
`were routinely processed for histologic evaluation. Im(cid:173)
`munohistochemical staining was performed by the avi(cid:173)
`din-biotin complex immunoperoxidase technique, using a
`commercial kit.e Tissue sections containing inclusion bodies
`suggestive ofPBFD virus were placed on slides coated with
`poly-L-lysine and dried overnight at 60 C. Tissue sections
`were deparaffinized, rinsed in deionized water, and treated
`for 15 minutes with 3% hydrogen peroxide to quench en(cid:173)
`dogenous peroxidase activity. The tissue sections were
`trypsinized, then rinsed in PBSS. Nonspecific staining was
`reduced by application of normal goat serum. Following
`blotting, the primary immunoglobulins were applied at a
`dilution of 1:2,000. Sections were incubated overnight at
`4 C. The slides were rinsed in PBSS, goat anti-rabbit im(cid:173)
`munoglobulin was applied (1:200 dilution), and the sec(cid:173)
`tions were incubated for 30 minutes at 25 C. After another
`rinse in PBSS, the avidin-biotin complex reagent was ap(cid:173)
`plied and the sections were incubated at 25 C for 1 hour.
`Tissue sections were again rinsed in PBSS, then developed
`for 6 minutes in a freshly prepared solution of hydrogen
`peroxide and diaminobenzidine substrate. Following a fi(cid:173)
`nal rinse in deionized water, the sections were counter(cid:173)
`stained with hematoxylin, dehydrated, coverslipped, and
`examined. Positive staining was indicated by the pres(cid:173)
`ence of a brown pigment. Negative controls for each spec(cid:173)
`imen were run by eliminating application of the primary
`antibody and substituting normal mouse serum at a 1:2,000
`dilution.
`
`Psittacine beak and feather disease virus recovery from
`neonates-Virus purification from the feathers of affected
`chicks was performed as described. Virus suspension (10
`f.Ll) from each bird was adsorbed onto 0.25% formvar-coated
`grids for 5 minutes, negatively stained with 1% phospho(cid:173)
`tungstic acid, and examined at 80 keV.r The virus prep(cid:173)
`aration used for challenge experiments was examined by
`electron microscopy in a similar fashion.
`
`Identification of viral DNA-Virus samples used for vac(cid:173)
`cinating adults, for challenging chicks, and recovered from
`the affected chicks were compared by the polymerase chain
`reaction (PCR), using PBFD virus-specific primers. Ten mi(cid:173)
`croliters of each purified virus preparation was mixed with
`90 f.Ll of PCR mixture containing 10 mM tris-HCI, pH 8.3,
`50 mM KCl, 25 mM MgCl, 0.1% gelatin, 200 f,LM each of
`dATP, dGTP, dCTP, and dTTP, 100 nM each of the for(cid:173)
`ward and reverse PCR primers, and 2.5 U of Taq DNA
`polymerase. The mixture was covered with mineral oil.
`Samples were subjected to 40 cycles of heating and cool-
`
`• Vector Laboratories, Burlingame, Calif.
`r JEOL JEM-100S, Peabody, Mass.
`
`1514
`
`ing, using a thermocycler.g Aliquots (10 f.Ll) of the PCR
`mixtures were subjected to electrophoresis on 2% agarose
`minigels in tris-borate-EDTA buffer according to estab.
`lished methods.22 Gels were stained with ethidium bro.
`mide, illuminated with short-wave uv light, and ph oto.
`graphed.
`
`Dot blots - Five microliters of PCR products was diluted
`to 50 f.Ll with tris-EDTA buffer, pH 8. Five microliters of
`4M N aOH was added to the mixture and was incubated
`at 72 C for 1 hour. The samples were cooled to 25 C and
`22 f.Ll of 1M ammonium acetate, pH 7.0 was added. Sam.
`pies were applied to neutral nylon membranesh in a dot.
`blot manifold under low vacuum and uv cross-linked be.
`fore probing. Membranes were probed and developed by
`use of a chemiluminescence detection systemh according
`to manufacturer's instructions.
`
`Results
`!3-Propiolactone-treated PBFD virus was used to inoc·
`ulate a group of 30- to 45-day-old and adult psittacine
`birds. Local tissue reactions to sc injections were mini·
`mal, with a few birds developing mild granuloma for(cid:173)
`mation at the site of the injection. Neither the HI nor
`precipitating antibody titers changed in a control bird
`inoculated with !3-propiolactone-treated PBSS.
`All the adult and neonate vaccinates had increased
`concentrations of HI antibodies by day 21 (Fig 1). Before
`vaccination, HI antibody titers in the adults ranged from
`1:80 to 1:640, with a geometric mean titer (GMT) of 201.
`In chicks, initial titers ranged from 1:40 to 1:640, with a
`GMT of 160. One week after the third vaccination, HI an·
`tibodies in the adults ranged from 1:1,280 to 1:5,120, with
`a GMT of 2,560; and titers in the chicks ranged from 1:1,280
`to 1:5,120, with a GMT of 2,986 (Table 1).
`Precipitating antibodies to the PBFD virus were de·
`tectable by the agar-gel diffusion test in serum from ex·
`perimentally vaccinated adult birds (Fig 2). A line of
`identity was evident when rabbit anti-PBFD antibodies or
`
`• Techne PHC-1 Programmable Dri-Block, Princeton, NJ.
`h Tropix Inc, Bedford, Mass.
`
`Titer
`
`pre 1wk 2wk 3wk pre 1wk 2wk 3wk pre 1wk 2wk 3wk
`
`Bird 1
`
`Bi rd 2
`
`Bird 3
`
`Figure 1-Microtitration plates of typical changes in hemagglutination in·
`hibition antibody titers of 3 adult psittacine birds after vaccination with ~·
`propiolactone-treated psittacine beak and feather disease (PBFD) virus.
`
`Am J Vet Res, Vol 53, No. 9, September 1992
`
`CEV Exhibit 1006_004
`
`

`

`T ble 1- Hemagglutination inhibition (HI) and precipitating antibody titers
`a:intervals a~er vacc_ination with 13-propiolactone-treated psittacine beak
`and feath er d1sease wus
`
`Postvaccination days
`0
`7
`14
`21
`640/10
`640 2,560 5,120/80
`160/1 1,280 2,560 5,120/80
`320/0
`640 5,120 5,120/80
`160/1
`320 640 1,280/10
`80/0 1,280 1,280 1,280/80
`320/1 1,280 2,560 2,560/80
`80/1
`160 2,560 2,560/10
`320/0
`160 2,560 2,560/10
`160/0 5,120 5,120 5,120/80
`< 40/0
`160 640 1,280/0
`< 40/0
`320 640 1,280/0
`
`Age and sex
`Species
`Adult male
`Moluccan cockatoo
`Adult male
`Umbrella cockatoo
`African grey parrot Adult male
`Adult female
`Moluccan cockatoo
`Adult male
`Umbrella cockatoo
`Adult female
`Umbrella cockatoo
`Adult female
`Umbrella cockatoo
`Adult male
`Amazon parrot
`African grey parrot Adult female
`45 d (sex unknown)
`Umbrella cockatoo
`45 d (sex unknown)
`Umbrella cockatoo
`Sulphur-crested
`45 d (sex unknown)
`80/0 2,560 2,560 2,560/0
`cockatoo
`45 d (sex unknown)
`160/0 2,560 2,560 5,120/0
`African grey parrot
`45 d (sex unknown)
`80/0
`320 640 2,560/0
`African grey parrot
`30 d (sex unknown)
`640/0 2,560 2,560 5,120/0
`African grey parrot
`30 d (sex unknown)
`640/0
`640 2,560 2,560/0
`African grey parrot
`30 d (sex unknown)
`640 .. .. 5,120/0
`640/0
`African grey parrot
`Titers on days 0 and 21 are listed as HI/precipitating.
`
`Figure 2-Agar-gel diffusion test of serum from an adult psittacine bird 3
`weeks after Initial vaccination. Precipitin lines are evident to a dilution of 1/
`80,
`
`inoculated bird serum was used. Precipitin lines were not
`evident when normal rabbit serum was used. Prior to
`vaccination, the precipitating antibody titers in the adults
`ranged from 0 to 1:10. All the adult birds produced pre(cid:173)
`cipitating antibodies by postvaccination day 21. The range
`of titers in the adults was 1:10 to 1:80, with a GMT of 40.
`Vaccinated chicks did not develop detectable concentra(cid:173)
`tions of precipitating antibodies (Table 1).
`. An African grey parrot and umbrella cockatoo hen vac(cid:173)
`Cinated with [3-propiolactone-treated PBFD virus serocon(cid:173)
`verted and had increases in HI and precipitating antibody
`co11:centrations (Table 2). By comparison, HI and precipi(cid:173)
`tating antibody titers in a nonvaccinated African grey
`Parrot and umbrella cockatoo hen were low (Table 2).
`Chicks from the vaccinated and nonvaccinated hens were
`~xposed to purified PBFD virus by the combined oral, in-
`racloacal, and sc routes. Chicks from vaccinated hens
`re~ained clinically normal throughout the 50-day test
`Perro d.
`
`Table 2-Hemagglutination inhibition and precipitating antibody titers in
`vaccinated and unvaccinated psittacine hens
`
`Vaccination
`Species
`status
`Vaccinated
`Umbrella cockatoo
`Vaccinated
`African grey parrot
`Unvaccinated
`Umbrella cockatoo
`African grey parrot
`Unvaccinated
`Titers on days 0 and 21 are listed as HI/precipitating.
`
`0
`160/1
`160/0
`
`Postvaccination days
`14
`7
`1,280
`2,560
`5,120
`5,120
`
`21
`5,120/80
`5,120/80
`160/0
`320/1
`
`The African grey parrot chick from the nonvaccinated
`hen developed normally until it was 30 days old, at which
`time the bird seemed depressed and began to regurgitate
`intermittently. Three days later, the bird started to lose
`powder-down and contour feathers. Several of the pri(cid:173)
`mary and secondary feather shafts appeared dark red(cid:173)
`brown and were loose in their follicles. Over the next 5
`days the bird continued to lose contour, flight, tail and
`crest feathers. The bird seemed increasingly depressed,
`and crop emptying slowed. The bird was euthanatized
`when it was 44 days old.
`The umbrella cockatoo chick from the nonvaccinated
`hen developed normally until it was 40 days old, at which
`time the bird seemed depressed and anorectic. Two days
`later, several primary and secondary feathers were loose
`in the follicles and contained dark-colored pulp cavities.
`Over the next 5 days, all of this bird's flight, tail, crest,
`and contour feathers begin to appear dystrophic. The bird
`died when it was 4 7 days old.
`Histologic evaluation of tissues from both affected chicks
`revealed basophilic intranuclear and intracytoplasmic in(cid:173)
`clusion bodies in feather epithelium, thymus, and bursa.
`Intranuclear inclusion bodies were located within epithe(cid:173)
`lial cells and intracytoplasmic inclusion bodies were in
`macrophages (Fig 3). Other histologic findings included
`necrosis and edema in the feathers.
`The affected African grey parrot and umbrella cockatoo
`chicks were confirmed to have PBFD by immunoper(cid:173)
`oxidase staining (Fig 3). Further, PBFD virus was re(cid:173)
`covered from the feathers of these birds, using established
`procedures. Virus recovered from the affected chicks was
`morphologically similar to the virus that was used for
`challenge exposure (Fig 4). Use of PBFD virus-specific DNA
`probes indicated that virus recovered from the infected
`chicks had the same nucleic acid sequence as the virus
`used to vaccinate the adults and challenge expose the
`chicks (Fig 5).
`
`Discussion
`Psittacine beak and feather disease virus has been as(cid:173)
`sociated with acute infections, which are most common
`in young psittacine birds, and chronic infections, which
`are most common in older psittacine birds.3 •8•
`16 The
`12
`15
`•
`•
`HI test has proven to be a rapid method for detecting anti(cid:173)
`PBFD virus antibodies. The presence of high concentra(cid:173)
`tions of HI antibodies in clinically normal birds naturally
`exposed to PBFD virus suggests that some birds encoun(cid:173)
`tering this virus develop subclinical infections that result
`in development of a protective immunologic response. 20
`Whether a bird is resistant to the virus or is fatally in(cid:173)
`fected could depend on the age of the bird at the time of
`infection, the presence and concentrations of maternal
`antibodies, the route of viral exposure, and/or the titer of
`the infecting virus.
`
`Am J Vet Res, Vol 53, No. 9, September 1992
`
`1515
`
`CEV Exhibit 1006_005
`
`

`

`1
`
`2
`
`3
`
`4
`
`5
`
`Figure 3-Photomicrograph of feather epithelium from an African grey par(cid:173)
`rot chick experimentally infected with PBFD virus. Intranuclear and intracy(cid:173)
`toplasmic inclusion bodies are located within infected epithelial cells and
`macrophages, respectively. Presence of PBFD virus antigen in intranuclear
`and intracytoplasmic inclusion bodies (arrows) is confirmed by use of viral(cid:173)
`specific antibodies and the immunoperoxidase technique with hematoxylin
`counterstain. Bar = 25 f!.m.
`
`Figure 4-Transmission electron micrograph of PBFD virus used to exper(cid:173)
`imentally infect psittacine chicks. Inset: Morphologically similar virus re(cid:173)
`covered from the feathers of an affected umbrella cockatoo chick. Virus
`suspensions were negatively stained with 1% phosphotungstic acid and
`photographed at 80 keV. Virus particles are 14 to 17 nm in diameter. Bar
`= 45 nm.
`
`1516
`
`Figure 5- Detection of PBFD virus nucleic acid by agar-gel electrophoresis
`and ethidium bromide staining. Arrow marks 400-base fragment. Lane 1,
`molecular weight standards; lane 2, nucleic acid from virus isolated from a
`Moluccan cockatoo and used to vaccinate breeding hens; lane 3, nucleic
`acid from virus isolated from an umbrella cockatoo and used to challenge
`expose chicks; lane 4, nucleic acid from virus isolated from an affected
`African grey parrot chick; lane 5, nucleic acid from virus isolated from an
`affected umbrella cockatoo chick.
`
`antibodies, the route of viral exposure, and/or the titer of
`the infecting virus.
`Because the manifestation of clinical changes in PBFD
`virus-infected birds can require a prolonged period and
`because latently infected birds may be difficult to detect,
`a vaccination program for this virus would provide the
`most practical solution for PBFD virus control. (3-Propi·
`olactone has been shown to inactivate all viruses against
`which it has been tested. 23 We did not determine whether
`the virus used in these studies was inactivated, but other
`studies have indicated that PBFD virus can be inactivated
`with (3-propiolactone.16
`In this study, HI and precipitating antibodies to the
`PBFD virus could be induced in adult psittacine birds after
`experimental vaccination with (3-propiolactone-treated
`PBFD virus. These findings suggest that a natural im·
`munologic response, which appears to develop in birds
`that are exposed to the PBFD virus, but remain clinicallY
`normal, can be experimentally reproduced. It was deter·
`mined in this study that passively derived HI antibodies
`did not prevent chicks from responding to vaccination by
`the time they were 30 to 45 days old. Titers from the
`individual chicks did not obtain the same level, but all
`birds had an increased HI antibody titer by 1-week after
`the third vaccination.
`Chicks used in this study did not have detectable con·
`centrations of maternally derived precipitating antibod·
`ies at the time of testing, and there was no detectable
`increase in this type of antibody following vaccination·
`
`Am J Vet Res, Vol 53, No. 9, September 1992
`
`CEV Exhibit 1006_006
`
`

`

`I poultry, IgG is the cla<>s of immunoglobulin in the serum
`~the tim~ of Jlatchi:r:g. 24 _If the HI antibodies ::rre ~gG and
`the precipitatmg antibodies are lgM, then this might ex(cid:173)
`plain why chicks did not have precipitating antibodies in
`their serum. Also, the agar-gel diffusion test is less sen(cid:173)
`sitive than is.the HI test. It is.possible that precipitating
`antibodies might have been mduced, but m concentra(cid:173)
`tions too low to be detected with this relatively insensi(cid:173)
`tive test system. Isotyping reagents for psittacine
`immunoglobulins, which to our knowledge are not avail(cid:173)
`able would be required to determine which types of im(cid:173)
`mudoglobulins are in the serum of chicks.
`The primary goal of the experiments described in this
`report was to develop a challenge model for testing a re(cid:173)
`combinant PBFD virus vaccine. A small sample size was
`used in this initial study because euthanasia of neonates
`in excess of that required to define the model could not
`be ethically justified. Umbrella cockatoo and African grey
`parrot chicks from vaccinated hens were found to be tem(cid:173)
`porarily resistant to PBFD virus challenge. Although the
`sample size was small, the fact that all of the chicks from
`vaccinated hens were temporarily resistant to infection,
`whereas control chicks from nonvaccinated hens devel(cid:173)
`oped clinical disease, and suggests that maternally trans(cid:173)
`mitted immunologic factors can protect neonates from virus
`challenge.
`Some previous attempts to infect budgerigars with
`feather homogenates containing PBFD virus have been
`unsuccessful. 16
`25 Passively derived protection may have
`•
`contributed to these transmission failures. Determining
`the level and type of antibodies that are needed to protect
`a bird from infection and the critical period when these
`antibodies provide protection from infection will require
`further investigation. Challenge exposing the vaccinated
`adults used in this project was beyond the scope and re(cid:173)
`sources of this study.
`Comparative studies of PBFD virus isolates recovered
`from various genera of psittacine birds have indicated
`that an antigenically similar virus infects a wide range
`of psittacine birds. 2 In the study reported here, virus pur(cid:173)
`ified from an umbrella cockatoo induced PBFD in anum(cid:173)
`brella cockatoo and an African grey parrot chick. Further,
`an umbrella cockatoo and African grey parrot hen vac(cid:173)
`cinated with [3-propiolactone-treated PBFD virus re(cid:173)
`covered from a Moluccan cockatoo produced chicks that
`remained normal after virus challenge. These findings
`strengthen the theory that an antigenically related virus
`causes PBFD in various psittacine genera.
`The experimentally infected psittacine chicks in this
`study were confirmed to have PBFD by use of viral-specific
`antibodies to demonstrate viral antigen in intranuclear
`and intracytoplasmic inclusion bodies. The DNA probe
`~omparison of the virus used for inducing antibody titers
`lU the adults, for challenging the chicks, and recovered
`from the affected chicks indicated that all of the viral
`preparations had a shared nucleic acid sequence. Further,
`PBFD virus could be recovered from the diseased feathers
`of the affected birds.
`r Galah chicks experimentally infected with PBFD virus
`have been reported to develop clinical signs of PBFD ap(cid:173)
`Proximately 4 weeks after infection. 16 In our study, the
`affected African grey parrot seemed depressed when it
`e Was 30 days old and developed progressive feather dys-
`trophy when it was 33 to 44 days old. The affected urn-
`1.
`
`brella cockatoo chick seemed depressed when it was 40
`days old and developed progressive feather dystrophy when
`it was 42 to 4 7 days old. The time variance in developing
`clinical signs associated with PBFD among psittacine chicks
`may be attributed to differences in concentrations of ma(cid:173)
`ternally transmitted antibodies, titer of virus in the in(cid:173)
`oculum, or host responses to the virus.
`Natural exposure to PBFD virus can occur from contact
`with contaminated feather dust, feces, or crop excre(cid:173)
`tions. 26 Because PBFD appears to be restricted in host range
`to psittacine birds and most of these birds are restricted
`to enclosures, it is likely that a widespread and continued
`vaccination program can be used to control this disease
`in companion birds in the United States. As demon(cid:173)
`strated by this study, vaccination of breeding females and
`subsequent transfer of passive immunity to developing
`chicks may be critical in pre

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket